NEW YORK, July 24, 2015 /PRNewswire/ --
Equity Research Institute has initiated coverage on the
following equities: Dover Corporation (NYSE: DOV), Cummins Inc.
(NYSE: CMI), Flowserve Corporation (NYSE: FLS), Colfax Corporation
(NYSE: CFX), and Rexnord Corporation (NYSE: RXN). Free research
report on Dover can be accessed at
https://www.EquityResearchInstitute.com/reports?keyword=DOV On
Thursday, July 23, 2015, the NASDAQ
Composite ended at 5,146.41, down 0.49%, the Dow Jones Industrial
Average declined 0.67%, to finish the day at 17,731.92, and the
S&P 500 closed at 2,102.15, down 0.57%. The losses were broad
based as eight out of nine sectors ended the session in negative.
Register for your complimentary reports at the links given below.
Dover Corp.'s stock edged 0.05% lower, to close Thursday's
session at $64.52. The stock recorded
a trading volume of 1.74 million shares, above its three months
average volume of 1.59 million shares. Over the last one month and
the previous three months, Dover Corp.'s shares have declined
11.08% and 12.80%, respectively. Additionally, the stock has lost
9.08% since the start of this year. The company is trading 10.32%
and 11.36% below its 50-day and 200-day moving averages,
respectively. Furthermore, Dover Corp.'s stock traded at a PE ratio
of 14.73 and has a Relative Strength Index (RSI) of 22.34. Sign up
and read the free notes on DOV at:
https://www.EquityResearchInstitute.com/reports?keyword=DOV
Cummins Inc.'s stock finished Thursday's session 0.20% lower at
$126.97. A total of 1.34 million
shares were traded, which was close to its three months average
volume of 1.38 million shares. Over the last one month and the
previous three months, Cummins Inc.'s shares have fallen by 6.41%
and 6.44%, respectively. Additionally, the stock has declined
10.94% since the beginning of 2015. The company's shares are
trading below their 50-day and 200-day moving averages by 5.98% and
8.13%, respectively. Cummins Inc.'s stock traded at a PE ratio of
13.61 and has an RSI of 29.01. The complimentary notes on CMI can
be downloaded in PDF format at:
https://www.EquityResearchInstitute.com/reports?keyword=CMI
On Thursday, shares in Flowserve Corp. ended the session 0.86%
lower at $47.54. The stock reported a
trading volume of 1.24 million shares, below its three months
average volume of 1.33 million shares. Shares of the company traded
at a PE ratio of 14.86. Flowserve Corp.'s shares have declined
11.83% in the last one month, 16.86% in the previous three months
and 20.03% on YTD basis. The stock is trading 10.74% below its
50-day moving average and 18.02% below its 200-day moving average.
Moreover, shares of Flowserve Corp. have an RSI of 27.52. Register
for free on Equity Research Institute and access the latest
research on FLS at:
https://www.EquityResearchInstitute.com/reports?keyword=FLS
Colfax Corp.'s stock lost 1.56%, to close the day at
$41.02. The stock recorded a trading
volume of 3.50 million shares, much above its three months average
volume of 0.86 million shares. Over the last one month and over the
past three months, Colfax Corp.'s shares have declined 13.88% and
16.58%, respectively. Furthermore, the stock has plummeted 20.46%
since the start of this year. The company's shares are trading
14.14% below their 50-day moving average. Additionally, Colfax
Corp. traded at a PE ratio of 12.94 and has an RSI of 15.46. The
complete research on CFX is available for free at:
https://www.EquityResearchInstitute.com/reports?keyword=CFX
On Thursday, shares in Rexnord Corp. recorded a trading volume
of 0.47 million shares, lower than their three months average
volume of 0.78 million shares. The stock ended the day 1.23% lower
at $21.73. Shares of the company
traded at a PE ratio of 24.98. Rexnord Corp.'s stock has lost
14.68% in the last one month, 17.84% in the previous three months
and 22.97% on YTD basis. The company is trading below its 50-day
and 200-day moving averages by 13.25% and 17.69%, respectively.
Furthermore, shares of Rexnord Corp. have an RSI of 22.69. Free
in-depth research on RXN is available at:
https://www.EquityResearchInstitute.com/reports?keyword=RXN
--
About Equity Research Institute:
Equity Research Institute ("ERI") produces regular sponsored and
non-sponsored reports, articles, stock market blogs, and popular
investment newsletters covering equities listed on NYSE and NASDAQ
and micro-cap stocks. ERI has two distinct and independent
departments. One department produces non-sponsored analyst
certified content generally in the form of press releases, articles
and reports covering equities listed on NYSE and NASDAQ and the
other produces sponsored content (in most cases not reviewed by a
registered analyst), which typically consists of compensated
investment newsletters, articles and reports covering listed stocks
and micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
ERI has not been compensated; directly or indirectly; for
producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the "CFA®"),
provides necessary guidance in preparing the document templates.
The Reviewer has reviewed and revised the content, as necessary,
based on sound investment judgment and publicly available
information which is believed to be reliable. The Reviewer and the
CFA® have not performed any independent investigations or forensic
audits to validate the information herein. Unless otherwise noted,
any content outside of this document has no association with the
Author, the Reviewer, or the CFA® (collectively referred to as the
"Production Team") in any way. The Production Team is compensated
on a fixed monthly basis and do not hold any positions of interest
in any of the securities mentioned herein.
NO WARRANTY
ERI, the Author, the Reviewer and the CFA® (collectively
referred to as the "Publishers") are not responsible for any error
which may be occasioned at the time of printing of this document or
any error, mistake or shortcoming. No liability is accepted by the
Publishers whatsoever for any direct, indirect or consequential
loss arising from the use of this document. The Publishers
expressly disclaim any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance
placed on the information in this document. Additionally, the
Publishers do not (1) guarantee the accuracy, timeliness,
completeness or correct sequencing of the information, or (2)
warrant any results from use of the information. The included
information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither ERI nor any party affiliated with us is a
registered investment adviser or broker-dealer with any agency or
in any jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit
http://www.equityresearchinstitute.com.
RESTRICTIONS
ERI is not available to residents of Belarus, Cuba, Canada,
Iran, North Korea, Sudan, Syria
or Somalia. Do not send email to
robottrap (at) equityresearchinstitute.com.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE www.equityresearchinstitute.com